Crisil ESG Ratings Assigns 'Crisil ESG 65' to Hikal for FY26
Hikal Ltd 路 Others (Uncategorized) 路 29 Sept 2026, 9:45 pm
Crisil ESG Ratings Assigns 'Crisil ESG 65' to Hikal for FY26 Crisil ESG Ratings & Analytics assigned an unsolicited ESG rating of 'Crisil ESG 65' to Hikal Limited for FY26 under the Pharmaceuticals sector, per its report dated 28th Sep'26. Hikal outperformed peers across renewable energy mix, waste recycling, low water withdrawal in stressed zones, employee safety, zero recalls, and low complaint intensity. Governance metrics reflected strong board diversity, high independent director attendance, and zero whistleblower or investor complaints. The independent rating was derived entirely from public domain data without direct company engagement.
Original exchange filing (PDF)
More announcements from Hikal Ltd
- Transcript of Earnings Call for the Quarter and half year ended September 30, 2026. 路 05 Nov 2026
- Audio Recording of Group Conference call for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Result presentation for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Announcement under Regulation 30 of SEBI LODR 2015- Press Release on the results of the Company for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Pursuant to Regulation 30(5) of the SEBI LODR Regulations- List of KMP authorized to determine materiality and make disclosures. 路 03 Nov 2026
- Unaudited Financial Results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Hikal Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
- Unaudited Financial Results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
